A Plus Biotechnology Co., Ltd. (TPE:6918)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Taiwan	727.17M	668.50M	595.90M
Taiwan Growth	8.78%	12.18%	-
Adjustment and Write-Off	-66.58M	-60.45M	-72.38M
China	175.30M	161.55M	151.52M
China Growth	8.51%	6.61%	-
Total	835.89M	769.59M	675.05M
Total Growth	8.61%	14.01%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Taiwan	653.27M	590.88M	515.49M
Taiwan Growth	10.56%	14.62%	-
China	175.30M	161.55M	151.52M
China Growth	8.51%	6.61%	-
Others	7.32M	17.17M	8.04M
Others Growth	-57.36%	113.68%	-
Total	835.89M	769.59M	675.05M
Total Growth	8.61%	14.01%	-

Source: S&P Global Market Intelligence.